Eva Malpass
HeartBeam accquires LIVMOR assets
HeartBeam, a cardiac technology company that has developed the three-dimensional (3D)-vector electro...
“Urgent” action needed to improve outcomes in women undergoing coronary artery bypass surgery
Women have been found to have significantly higher risk of operative mortality and postoperative...
Analysis finds clinical trials frequently overlook people with disabilities
Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion fr...
Poor, irregular sleep linked to increased atherosclerosis in adults 45 and above
Sleeping an inconsistent number of hours each night and falling asleep at different times may in...
PCI probability seen to increase at low-volume hospitals for all populations, but has not occurred “evenly” across sociodemographic groups
A retrospective cohort study has found the likelihood of receiving percutaneous coronary interve...
Cardiovascular News’ top 10 most popular stories of January 2023
In the opening month of 2023, Cardiovascular News’ most read stories include sex disparities in clin...
The interventional cardiology trials to watch in 2023
Trials in coronary imaging, transcatheter tricuspid valve interventions, transcatheter aortic va...
BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system
BioVentrix, a privately held medical device company focused on the development of less invasive ther...
Non-invasive wearable ultrasound sensor shown to provide mobile cardiac imaging
A group of engineers and physicians have created a wearable ultrasonic device that is able to pr...
Improved follow-up care needed for Black patients post-PCI to prevent hospital readmission and death
In a recent study which revealed higher readmission and mortality rates among Black patients fol...
Study finds PET technology more effective to determining need for coronary stents bypass surgery
A new method for determining whether patients with heart disease need coronary stents or bypass ...
Otsuka Medical Devices and ReCor Medical submit pre-market approval of Paradise ultrasound renal denervation system
Otsuka Medical Devices and ReCor Medical, a subsidiary of Otsuka, announce the filing ...
Ninety-day readmission and mortality found to be higher among Black patients following PCI
A retrospective analysis of data collected from the Blue Cross Blue Shield of Michigan Cardiovascula...
